BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 10397246)

  • 1. Alterations of Fas (APO-1/CD95) gene in transitional cell carcinomas of urinary bladder.
    Lee SH; Shin MS; Park WS; Kim SY; Dong SM; Pi JH; Lee HK; Kim HS; Jang JJ; Kim CS; Kim SH; Lee JY; Yoo NJ
    Cancer Res; 1999 Jul; 59(13):3068-72. PubMed ID: 10397246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic approaches targeting CD95L/CD95 signaling in cancer and autoimmune diseases.
    Risso V; Lafont E; Le Gallo M
    Cell Death Dis; 2022 Mar; 13(3):248. PubMed ID: 35301281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variations in the
    Dardiotis E; Siokas V; Garas A; Paraskevaidis E; Kyrgiou M; Xiromerisiou G; Deligeoroglou E; Galazios G; Kontomanolis EN; Spandidos DA; Tsatsakis A; Daponte A
    Oncol Lett; 2018 Sep; 16(3):3833-3841. PubMed ID: 30127996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between FAS rs2234767 and FASL rs763110 polymorphisms and the risk of lung cancer: a meta-analysis of 39,736 subjects.
    Yu X; Li Y; Yu Y; Lei J; Wan G; Cao F
    Onco Targets Ther; 2016; 9():2049-56. PubMed ID: 27103831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative assessment of the association between Fas/FasL gene polymorphism and susceptibility to esophageal carcinoma in a north Chinese population.
    Zhang M; Wu C; Li B; Du W; Zhang C; Chen Z
    Cancer Med; 2016 Apr; 5(4):760-6. PubMed ID: 26819081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combined risks of reduced or increased function variants in cell death pathway genes differentially influence cervical cancer risk and herpes simplex virus type 2 infection among black Africans and the Mixed Ancestry population of South Africa.
    Chattopadhyay K; Williamson AL; Hazra A; Dandara C
    BMC Cancer; 2015 Oct; 15():680. PubMed ID: 26458812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic association between CD95 rs2234767 polymorphism and cervical cancer risk: a meta analysis.
    Liu P; Wei Z; He X; Yu J; Tian X; Chang J
    Int J Clin Exp Med; 2015; 8(2):2357-63. PubMed ID: 25932173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FAS-670 gene polymorphism and cervical carcinogenesis risk: A meta-analysis.
    Huang Q; Wang J; Hu Y
    Biomed Rep; 2013 Nov; 1(6):889-894. PubMed ID: 24649048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Death receptor (DR4) haplotypes are associated with increased susceptibility of gallbladder carcinoma in north Indian population.
    Rai R; Sharma KL; Sharma S; Misra S; Kumar A; Mittal B
    PLoS One; 2014; 9(2):e90264. PubMed ID: 24587306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional polymorphisms in FAS/FASL system increase the risk of neuroblastoma in Chinese population.
    Han W; Zhou Y; Zhong R; Wu C; Song R; Liu L; Zou L; Qiao Y; Zhai K; Chang J; Huang L; Liu L; Lu X; Lou J; Yu D; Tan W; Zhang J; Wang H; Miao X
    PLoS One; 2013; 8(8):e71656. PubMed ID: 23951214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of association between Fas rs180082 polymorphism and risk of cervical cancer: an update by meta-analysis.
    Chen X; Mo W; Peng Q; Su X
    BMC Med Genet; 2013 Jul; 14():71. PubMed ID: 23865866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD95-mediated cell signaling in cancer: mutations and post-translational modulations.
    Tauzin S; Debure L; Moreau JF; Legembre P
    Cell Mol Life Sci; 2012 Apr; 69(8):1261-77. PubMed ID: 22042271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases.
    Strasser A; Cory S; Adams JM
    EMBO J; 2011 Aug; 30(18):3667-83. PubMed ID: 21863020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Polymorphism of Cancer Susceptibility Genes and HPV Infection in Cervical Carcinogenesis.
    Nunobiki O; Ueda M; Toji E; Yamamoto M; Akashi K; Sato N; Izuma S; Torii K; Tanaka I; Okamoto Y; Noda S
    Patholog Res Int; 2011; 2011():364069. PubMed ID: 21660264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular stress responses: cell survival and cell death.
    Fulda S; Gorman AM; Hori O; Samali A
    Int J Cell Biol; 2010; 2010():214074. PubMed ID: 20182529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fas and FasL gene polymorphisms are not associated with cervical cancer but differ among Black and Mixed-ancestry South Africans.
    Chatterjee K; Engelmark M; Gyllensten U; Dandara C; van der Merwe L; Galal U; Hoffman M; Williamson AL
    BMC Res Notes; 2009 Nov; 2():238. PubMed ID: 19941645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FAS promoter polymorphism: outcome of childhood acute myeloid leukemia. A children's oncology group report.
    Mehta PA; Gerbing RB; Alonzo TA; Elliott JS; Zamzow TA; Combs M; Stover E; Ross JA; Perentesis JP; Meschinchi S; Lange BJ; Davies SM
    Clin Cancer Res; 2008 Dec; 14(23):7896-9. PubMed ID: 19047119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of the Fas-receptor/Fas-ligand system in cervical squamous cell carcinoma.
    Lerma E; Romero M; Gallardo A; Pons C; Muñoz J; Fuentes J; Lloveras B; Catasus L; Prat J
    Virchows Arch; 2008 Jan; 452(1):65-74. PubMed ID: 18000680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FASL -844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer.
    Sun T; Zhou Y; Li H; Han X; Shi Y; Wang L; Miao X; Tan W; Zhao D; Zhang X; Guo Y; Lin D
    J Exp Med; 2005 Oct; 202(7):967-74. PubMed ID: 16186185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional polymorphisms in cell death pathway genes FAS and FASL contribute to risk of lung cancer.
    Zhang X; Miao X; Sun T; Tan W; Qu S; Xiong P; Zhou Y; Lin D
    J Med Genet; 2005 Jun; 42(6):479-84. PubMed ID: 15937082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.